- Home
- AVT vs IMVT Comparison
AVT vs IMVT Comparison
Compare AVT & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVT
- IMVT
- Stock Information
- Founded
- AVT 1921
- IMVT N/A
- Country
- AVT United States
- IMVT United States
- Employees
- AVT N/A
- IMVT N/A
- Industry
- AVT Electronic Components
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVT Technology
- IMVT Health Care
- Exchange
- AVT Nasdaq
- IMVT Nasdaq
- Market Cap
- AVT 4.8B
- IMVT 4.2B
- IPO Year
- AVT N/A
- IMVT N/A
- Fundamental
- Price
- AVT $53.07
- IMVT $25.86
- Analyst Decision
- AVT Sell
- IMVT Strong Buy
- Analyst Count
- AVT 4
- IMVT 11
- Target Price
- AVT $48.50
- IMVT $47.60
- AVG Volume (30 Days)
- AVT 1.0M
- IMVT 952.1K
- Earning Date
- AVT 01-29-2025
- IMVT 02-10-2025
- Dividend Yield
- AVT 2.41%
- IMVT N/A
- EPS Growth
- AVT N/A
- IMVT N/A
- EPS
- AVT 3.83
- IMVT N/A
- Revenue
- AVT $23,025,633,000.00
- IMVT N/A
- Revenue This Year
- AVT N/A
- IMVT N/A
- Revenue Next Year
- AVT $7.99
- IMVT N/A
- P/E Ratio
- AVT $13.86
- IMVT N/A
- Revenue Growth
- AVT N/A
- IMVT N/A
- 52 Week Low
- AVT $43.62
- IMVT $24.61
- 52 Week High
- AVT $59.24
- IMVT $45.58
- Technical
- Relative Strength Index (RSI)
- AVT 42.50
- IMVT 38.95
- Support Level
- AVT $52.20
- IMVT $26.19
- Resistance Level
- AVT $54.87
- IMVT $28.08
- Average True Range (ATR)
- AVT 1.25
- IMVT 1.12
- MACD
- AVT -0.19
- IMVT -0.22
- Stochastic Oscillator
- AVT 22.54
- IMVT 14.39
About AVT Avnet Inc.
Avnet Inc is a global distributor of electronic components, connecting suppliers of semiconductors and other components to a base of 2.1 million small- and mid-sized customers in 140 countries. Avnet is the third largest semiconductor distributor in the world, and the largest for European chip distribution. Avnet services all levels of electronics design and development, servicing engineers with design tools, test kits, and services alongside its high-volume distribution for final designs.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).